April 9 (Reuters) - France&aposs Haute Autorite de Sante regulator:
NO REASON TO FEAR SPECIFIC ADVERSE EVENTS LINKED TO ADMINISTRATION OF SECOND DOSE WITH COVID-19 MRNA VACCINE POST FIRST INJECTION WITH ASTRAZENECA
(Paris Newsroom)
April 9 (Reuters) - France&aposs Haute Autorite de Sante regulator:
NO REASON TO FEAR SPECIFIC ADVERSE EVENTS LINKED TO ADMINISTRATION OF SECOND DOSE WITH COVID-19 MRNA VACCINE POST FIRST INJECTION WITH ASTRAZENECA
(Paris Newsroom)
Use the share button in your browser
to share the page with your friends